Serratus Posterior Superior Intercostal Plane Block
Evaluation of the Efficacy of Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block For Postoperative Analgesia in Thoracic Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
Background: Adequate pain control after video-assisted thoracoscopic surgery (VATS) remains a major clinical challenge. Traditional techniques such as thoracic epidural analgesia are effective but limited by potential complications. Interfascial plane blocks have recently gained interest as safer alternatives. The serratus posterior superior intercostal plane block (SPSIPB) is a novel regional anesthesia technique with potential benefits in thoracic surgery. Objective: The purpose of this study was to evaluate the analgesic efficacy of ultrasound-guided SPSIPB compared with subcutaneous morphine administration in patients undergoing VATS. Methods: In this prospective, randomized controlled trial, 60 patients scheduled for elective VATS were randomized into two groups: SPSIPB group (n=30) and control group receiving subcutaneous morphine (n=30). The primary outcome was postoperative pain intensity measured by the visual analog scale (VAS) at rest and during coughing. Secondary outcomes included opioid consumption, number of patient-controlled analgesia (PCA) demands, rescue analgesia requirements, and incidence of adverse effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 9, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedJanuary 9, 2026
January 1, 2026
6 months
December 9, 2025
January 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Intensity
Pain intensity was assessed using the Visual Analog Scale (VAS; 0 = no pain, 10 = worst pain imaginable) at rest and during coughing.
24 hours after surgery (measured at 0, 2, 4, 8, 16, and 24 hours)
Secondary Outcomes (1)
Total opioid consumption within 24 hours
24 hours after surgery (cumulative from 0 to 24 hours)
Study Arms (2)
SPSIPB Group
EXPERIMENTALPatients received an ultrasound-guided SPSIPB with 20 mL local anesthetic at the end of surgery.
Active Comparator
ACTIVE COMPARATORPatients received a subcutaneous morphine injection according to institutional standard practice after surgery.
Interventions
Intervention Type: Procedure (Regional Anesthesia) Name: Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block (SPSIPB) Description: A single injection of 20 mL of local anesthetic was administered under ultrasound guidance into the serratus posterior superior intercostal plane at the end of surgery.
Intervention Type: Drug (Morphine) Name: Subcutaneous Morphine Description: Patients received a single subcutaneous injection of morphine (dose according to institutional standard practice) after surgery.
Eligibility Criteria
You may qualify if:
- Age between 18 and 70 years
- American Society of Anesthesiologists (ASA) physical status I-III
- Scheduled for elective video-assisted thoracoscopic surgery (VATS) under general anesthesia
- Provision of written informed consent
You may not qualify if:
- Conversion to thoracotomy during surgery
- Coagulopathy or ongoing anticoagulant therapy
- Local infection at the injection site
- Known allergy to local anesthetics or morphine
- Severe cardiopulmonary disease contraindicating regional anesthesia
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziantep University
Gaziantep, 27410, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elzem Şen, Assoc. Prof
University of Gaziantep
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
December 9, 2025
First Posted
January 9, 2026
Study Start
February 2, 2024
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
January 9, 2026
Record last verified: 2026-01